Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Recent advances in graves ophthalmopathy medical therapy: a comprehensive literature review
source: International Ophthalmology
year: 2023
authors: Xueting Li, Senmao Li, Wanlin Fan, Alexander C Rokohl, Sitong Ju, Xiaojun Ju, Yongwei Guo, Ludwig M Heindl
summary/abstract:Graves ophthalmopathy (GO), which occurs in autoimmune thyroid disease, can reduce patients’ quality of life due to its impact on visual function, physical appearance, and emotional health. Corticosteroids have been the first-line treatment for GO. More recently, the pathogenesis of GO has made significant progress. Various targeting biological agents and immunosuppressive agents make GO management more promising. Fully understanding GO pathogenesis and precise clinical management are beneficial for the prognosis of patients. Therefore, we conducted a comprehensive review of the medical management of GO and summarized research developments to highlight future research issues.
organization: University of Cologne, Germany; Aachen-Bonn-Cologne-Duesseldorf, Germany; Zhejiang University School of Medicine, ChinaDOI: 10.1007/s10792-022-02537-6
read more full text
myBinderRelated Content
-
Controversies in the Pharmacological Treatment of Graves’ Disease in ChildrenGraves' disease (GD) is a disorder, in w...
-
Radioactive Iodine Therapy vs. Antithyroid Medications for Graves’ DiseaseGraves disease is the most common cause ...
-
Dealing With Thyroid Eye Disease: Patient and Physician PerspectivesJoin us for a webinar hosted by the Grav...
-
The New England Journal of Medicine Publishes Comprehensive Data From Phase 3 Clinical Trial (OPTIC) of TEPEZZA™ (...Horizon Therapeutics plc announced that ...
-
Patient Story – Thyroid Eye Diseasehttps://www.youtube.com/watch?v=GnXbXSah...
-
Relation Between Therapy for Hyperthyroidism and the Course of Graves’ OphthalmopathyBackground: The chief clinical characte...
-
Management of Fetal and Neonatal Graves’ DiseaseFetal and neonatal autoimmune hyperthyro...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Facebook
Google